Explore the latest advancements in rheumatology biosimilars, including FDA approvals, patient switching trends, and ...

Pediatric infliximab biosimilar use has risen significantly, reflecting evolving treatment patterns in inflammatory bowel ...

To read all of these articles and more, visit centerforbiosimilars.com.

The debate over the Biosimilar Red Tape Elimination Act raises critical concerns about FDA standards, physician trust, and ...

Josh Canavan, PharmD, RazorMetrics, and Chris O'Dell, Turquoise Health, explain that widespread biosimilar adoption requires addressing patient and provider education gaps through pharmacists and ...

Number 5: The new data were collected to fulfill the FDA's requirements to designate adalimumab-fkjp (Hulio) as ...

A real-world study reveals that pediatric patients with IBD achieve high remission rates and cost savings using adalimumab ...

CHMP Green Lights Aflibercept Candidate. Alvotech and Advanz Pharma announced that the European Medicines Agency's CHMP has issued a positive opinion, recommending approval for AVT06, a proposed ...